Finance

Lists
ADPT:NASDAQ
Adaptive Biotechnologies Corp
29,40 USD
-1,80%
(-0,54) 1D
12-ноя., 13:14:48 GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ADPT...
Open
29,20 USD
High
29,78 USD
Low
28,59 USD
Mkt. cap
4,76 млд
Avg. vol.
2,29 млн
Volume
546,72 миң
52-wk high
32,13 USD
52-wk low
12,00 USD
EPS
-0,45 USD
Beta
2,18
Shares outstanding
161,88 млн
No. of employees
624
Open
29,20 USD
High
29,78 USD
Low
28,59 USD
Mkt. cap
4,76 млд
Avg. vol.
2,29 млн
Volume
546,72 миң
52-wk high
32,13 USD
52-wk low
12,00 USD
EPS
-0,45 USD
Beta
2,18
Shares outstanding
161,88 млн
No. of employees
624
News stories
From web sources and news partners
About Adaptive Biotechnologies Corp
CEOChad Robins
Employees624
Founded2009
HeadquartersСиэтл, Вашингтон, Америка Кошмо Штаттары
SectorHealth Care
Industry-
Analyst ratings
Based on 8 analysts giving stock ratings to ADPT in the past 3 months
Strong buy
Buy
7
Hold
1
Sell
0
12-month forecast
Based on 8 Wall Street analysts offering 12 month price targets for ADPT in the last 3 months.
Highest
Current 29,40 USD
35,00 USD (+19,05%)
Average
33,43 USD (+13,71%)
Lowest
27,00 USD (-8,16%)
Analyst
Recommendation
Action
Price target
Projected
Date
David Westenberg
Piper Sandler
Buy
Reiterated
35,00 USD
+19%
11/10/2026
Subbu Nambi
Guggenheim
Buy
Reiterated
34,00 USD
+15,6%
11/10/2026
Casey Woodring
J.P. Morgan
Buy
Reiterated
35,00 USD
+19%
11/09/2026
Mark Massaro
BTIG
Buy
Reiterated
34,00 USD
+15,6%
11/05/2026
Daniel Brennan
TD Cowen
Buy
Reiterated
34,00 USD
+15,6%
11/05/2026
Kallum Titchmarsh
Morgan Stanley
Hold
Maintained
27,00 USD
-8,2%
10/13/2026
Evie Koslosky
Goldman Sachs
Buy
Initiated
35,00 USD
+19%
09/29/2026
William Bonello
Craig-Hallum
Buy
Maintained
-
-
09/17/2026
Sebastian Sandler
J.P. Morgan
Buy
Maintained
27,00 USD
-8,2%
07/30/2026
Matt Larew
William Blair
Buy
Maintained
-
-
07/30/2026
Andrew Brackmann
William Blair
Buy
Reiterated
-
-
06/16/2026
Last report
2026-ж., 4-ноя.
Fiscal period
Q3 2026
0,02 USD / -0,10 USD
+120,31%beat
Revenue / Est. (USD)
83,90 млн / 71,60 млн
+17,18%beat
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
2026-ж. сен.
Revenue
71,68 млн
70,87 млн
71,55 млн
83,90 млн
Cost of goods sold
39,99 млн
42,33 млн
39,32 млн
38,57 млн
Cost of revenue
39,99 млн
42,33 млн
39,32 млн
38,57 млн
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
44,04 млн
47,33 млн
47,58 млн
45,36 млн
Operating expense
44,47 млн
47,75 млн
48,00 млн
45,79 млн
Total operating expenses
84,45 млн
90,08 млн
87,32 млн
84,36 млн
Operating income
-12,77 млн
-19,21 млн
-15,77 млн
-457,00 миң
Other non operating income
-
-
-
-
EBT including unusual items
-13,58 млн
-20,02 млн
-39,94 млн
2,81 млн
EBT excluding unusual items
-13,87 млн
-20,15 млн
-16,21 млн
2,81 млн
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-13,58 млн
-20,03 млн
-39,79 млн
2,88 млн
Net profit margin
-18,94%
-28,27%
-55,61%
3,43%
Earnings per share
-0,09
-0,13
-0,25
0,02
Interest and investment income
1,86 млн
1,94 млн
2,26 млн
3,77 млн
Interest expense
-2,95 млн
-2,89 млн
-2,69 млн
-503,00 миң
Net interest expenses
-1,09 млн
-945,00 миң
-438,00 миң
3,26 млн
Depreciation and amortization charges
-
-
-
-
EBITDA
-8,58 млн
-15,37 млн
-12,08 млн
3,15 млн
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google колдонмолору